home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

Biomarkers Discovery & Development Congress

  November 28, 2005  
Oxford International, Manchester, UK
27 - 28 Feb 2006

An essential industry update, you will have the opportunity to hear the latest industry case studies, focusing on:
• Strategy: Biomarkers as a means of empowering decision-making, reducing costs and increasing productivity
• Technologies: Imaging biomarkers and molecular biomarkers
• Biomarkers as markers of activity and surrogate endpoints
• Regulation: Constraints and challenges
• Biomarkers in the preclinical phase
• Efficacy models
• Metabolomic, genomic and proteomic applications
• Clinical validation of biomarkers
• Toxicity biomarkers: safety, validation and efficacy testing
Organized by: Oxford International
Invited Speakers: Confirmed Speakers:
**Dr. Allen Roses**, Senior Vice President, Genetics Research, GlaxoSmithKline;
**Dr. John Ryan**, Vice President, Experimental Medicine, Wyeth;
**Dr. Thomas Henkel**, Vice President, Pharma Research and Development, Bayer HealthCare;
**Dr. Richard Hargreaves**, Vice President, Imaging, Merck & Co;
**Dr. Rakesh Dixit**, Senior Director, Toxicology, Johnson & Johnson;
**Dr. Hakan Wennbo**, Director, Discovery Medicine, Cardiovascular/Gastrointestinal, AstraZeneca;
**Dr. Holly Hilton**, Research Informatics, Genetics and Genomics, F. Hoffmann-La Roche;
**Dr. Orest Hurko**, Assistant Vice President, Translational Research, Wyeth;
**Dr. David Friedman**, Associate Director, Biomarker Technology, Vertex Pharmaceuticals;
**Dr. Peter O'Brien**, Head, Discovery Toxicology Biomarkers and Safety Sciences, Pfizer;
**Dr. Georg Wensing**, Head, Pharmacodynamics, Clinical Pharmacology, Bayer Healthcare;
**Dr. Harsukh Parmar**, Director, Global Discovery Medicine, AstraZeneca;
**Dr. Stefan Kass**, Head, Genomic Technologies, Johnson & Johnson;
**Dr. Huw Alun Davies**, Manager, UK and Denmark Biomarker Discovery Centers®, Ciphergen; Senior Representative, Oxford Genome Sciences; Senior Representative, Medical Solutions
Deadline for Abstracts: 20 Dec 2005
Registration: For more information and registration details, please email: congressmarketing@oxfordint.co.uk, or call Louisa Carson on: +44 (0) 8701 601 011 quoting HUM-MOLGEN.
E-mail: lcarson@oxfordint.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.